Results-driven and highly skilled Medical Oncologist with a decade of extensive experience in diagnosing and treating various cancers. Proven expertise in developing and implementing personalized treatment plans, utilizing cutting-edge medical technologies and evidence-based practices. Adept at collaborating with multidisciplinary teams to ensure comprehensive patient care and optimal outcomes.
Demonstrated leadership in clinical research, contributing to advancements in oncology knowledge. Compassionate and patient-focused, dedicated to providing empathetic support throughout the treatment journey. Seeking to leverage a decade of expertise to continue making meaningful contributions to cancer care and research.
Experienced with diagnosis and treatment of solid and hematological cancers.
Experience of participating in a multidisciplinary tumor board.
Exposure to all types of modern investigations and radiological interventions.
Exposure to theragnostic with advances in nuclear medicine.
Exposure to modern surgical procedures, including robotic surgery and HIPEC.
Exposure to modern Radiotherapy including SRT and SBRT.
Hands-on training with modern medicine (targeted agents, Immune checkpoint inhibitors, chemotherapy).
Hands-on training in BMT.
Hands-on training in critical care in ICU, HDU.
Conducting clinical research.
Conducting and managing day care patients with chemotherapy, IO administration with various types of central lines including PICC, Chemo port in a tertiary cancer center.
IPD patient rounds with individualized treatment decisions.
Outcome of Surveillance Stool Culture and Sensitivity, followed by needful intervention in patients undergoing hematopoietic stem cell transplant at a Tertiary Care Teaching Hospital in Eastern India. © 2026 Archives of Medicine and Health Sciences | Published by Wolters Kluwer - Medknow https://journals.lww.com/armh DOI: 10.4103/amhs.amhs_188_24 Shipla Roy, Poulami Nandi, Sandeep Saha, Shuvra Neel Baul, Sayoni Bhanja, Rajib De, Tuphan Kanti Dolai Department of Haematology, NRS Medical College and Hospital Department of Microbiology, NRS Medical College and Hospital Department of Oncology, Apollo Multispecialty Hospitals
ASCO-Abstract#276367: Tumor-associated myeloid-derived suppressor cells as a potential biomarker for prognostication of response in treatment of diffuse large cell lymphoma. Asia Pacific Journal of Cancer Care, 8(3), Pages 477-482 https://coi.asco.org/Report/ViewAbstractCOI?id=276367
Goyel, D., Maji, T., Lahiri, D., Roy, S., Bhanja, S., Rangineni, S., Kumar Ray, D., Kumar Mahanta, B., Kumar Misra, D. De, P. (2023). Hippocampal avoidance whole brain radiotherapy in brain metastasis using volumetric modulated arc therapy: experience from a Regional Cancer Centre of Eastern India. Reports of Practical Oncology and Radiotherapy 2023, Volume 28, Number 4, Pages 468-477 (DOI: 10.5603/RPOR.a2023.0048)
Bhanja, S., Lahiri, D., Roy, S., Maji, T., & De, P. (2023). Comparison of Safety and Efficacy of Two Different Chemotherapy Dosing Schedules used in Concurrent Chemoradiation of Head and Neck Cancer: A Retrospective Experience from a Tertiary Cancer Care Institute of Eastern India.
.jpeg)
MBBS, MD Radiation Oncology
HCG Cancer Hospital, Kolkata
Book an Appointment.jpg)
MBBS, DNB (General Surgery), Post-Doctoral Fellowship (Surgical Oncology and Uro-oncosurgery)
HCG Cancer Hospital, Kolkata
Book an AppointmentFeel free to reach out to us.
